These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18981065)

  • 1. New findings on antipsychotic use in children and adolescents with schizophrenia spectrum disorders.
    Ross RG
    Am J Psychiatry; 2008 Nov; 165(11):1369-72. PubMed ID: 18981065
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychopharmacologic treatment of psychosis in children and adolescents: efficacy and management.
    Kranzler HN; Cohen SD
    Child Adolesc Psychiatr Clin N Am; 2013 Oct; 22(4):727-44. PubMed ID: 24012083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atypical antipsychotic agents in the adolescent: what implications for the future?].
    Cohen D
    Encephale; 2011 Sep; 37(4 Suppl 4):H15-7. PubMed ID: 22108183
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychosis in Children and Adolescents.
    McClellan J
    J Am Acad Child Adolesc Psychiatry; 2018 May; 57(5):308-312. PubMed ID: 29706159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirical evidence for psychopharmacologic treatment in early-onset psychosis and schizophrenia.
    Maloney AE; Yakutis LJ; Frazier JA
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):885-909. PubMed ID: 23040906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotection: a new strategy in the treatment of schizophrenia. Early detection and intervention.
    Perkins DO
    CNS Spectr; 2007 Oct; 12(10 Suppl 18):10-3. PubMed ID: 19322959
    [No Abstract]   [Full Text] [Related]  

  • 7. Antipsychotics in adolescent-onset psychosis: a work in progress.
    James AC; Broome MR
    Lancet Psychiatry; 2017 Aug; 4(8):e16-e17. PubMed ID: 28748801
    [No Abstract]   [Full Text] [Related]  

  • 8. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug treatment of functional psychotic disorders].
    Bridler R; Umbricht D; Hell D
    Praxis (Bern 1994); 2001 May; 90(22):981-6. PubMed ID: 11450186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All antipsychotics are equal, but some are more equal than others.
    Volavka J; Citrome L
    J Clin Psychiatry; 2009 Mar; 70(3):429-30. PubMed ID: 19317959
    [No Abstract]   [Full Text] [Related]  

  • 11. Risperidone in adolescents.
    Cozza SJ; Edison DL
    J Am Acad Child Adolesc Psychiatry; 1994 Oct; 33(8):1211. PubMed ID: 7527022
    [No Abstract]   [Full Text] [Related]  

  • 12. ["Sluggish schizophrenia" (concerning the article by A.B. Smulevich and P.V. Mikhalev (S.S. Korsakov zhurnal nevropatologii i psikhiatrii, No. 12, l987, pp. 186-187].
    Aliev N
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(2):132. PubMed ID: 1355941
    [No Abstract]   [Full Text] [Related]  

  • 13. [For: is monotherapy the gold standard of psychopharmacology?].
    Fehr C
    Psychiatr Prax; 2006 Jul; 33(5):207-8. PubMed ID: 16802258
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimizing outcomes in schizophrenia: long-acting depots and long-term treatment.
    Morrissette DA; Stahl SM
    CNS Spectr; 2012 Nov; 17 Suppl 1():10-21. PubMed ID: 23462201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain volume changes in schizophrenia: how do they arise? What do they mean?
    Lewis DA
    Psychol Med; 2009 Nov; 39(11):1779-80. PubMed ID: 19379533
    [No Abstract]   [Full Text] [Related]  

  • 16. Drugs for psychotic disorders.
    Treat Guidel Med Lett; 2010 Aug; 8(96):61-4; quiz two pages following last numbered page.. PubMed ID: 20651640
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic late-onset schizophrenia-like psychosis that remitted: revisiting Newton's psychosis?
    Jeste DV; Harless KA; Palmer BW
    Am J Psychiatry; 2000 Mar; 157(3):444-9. PubMed ID: 10698822
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of antipsychotics on brain structure: what have we learnt from structural imaging of schizophrenia?
    Borgwardt SJ; Smieskova R; Fusar-Poli P; Bendfeldt K; Riecher-Rössler A
    Psychol Med; 2009 Nov; 39(11):1781-2. PubMed ID: 19476691
    [No Abstract]   [Full Text] [Related]  

  • 19. [Childhood and adolescent-onset schizophrenia: new information and definitions].
    Amitai M; Sever Y; Weizman A; Zalsman G
    Harefuah; 2012 Sep; 151(9):550-3, 554. PubMed ID: 23367752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Against: is monotherapy the gold standard of psychopharmacology?].
    Bechter K
    Psychiatr Prax; 2006 Jul; 33(5):208-10. PubMed ID: 16874937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.